Reply to van Gils et al.

Jie Xu; Lili Cai; Bota Cui

doi:10.1055/a-2208-7019

Endoscopy, Inhaltsverzeichnis

Endoscopy 2024; 56(02): 158-159
DOI: 10.1055/a-2208-7019

Letter to the editor

Reply to van Gils et al.

Jie Xu

¹Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China (Ringgold ID: RIN637622)

²Key Lab of Holistic Integrative Enterology, Nanjing Medical University, Nanjing, China (Ringgold ID: RIN12461)

,

Lili Cai

³Digestive Endoscopy and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China (Ringgold ID: RIN637622)

,

Bota Cui

¹Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China (Ringgold ID: RIN637622)

²Key Lab of Holistic Integrative Enterology, Nanjing Medical University, Nanjing, China (Ringgold ID: RIN12461)

References
1 Kiesslich R, Duckworth CA, Moussata D. et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012; 61: 1146-1153
2 Karstensen JG, Săftoiu A, Brynskov J. et al. Confocal laser endomicroscopy: a novel method for prediction of relapse in Crohnʼs disease. Endoscopy 2016; 48: 364-372
3 Chang J, Leong RW, Wasinger VC. et al. Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing. Gastroenterology 2017; 153: 723-731.e1
4 Lim LG, Neumann J, Hansen T. et al. Confocal endomicroscopy identifies loss of local barrier function in the duodenum of patients with Crohnʼs disease and ulcerative colitis. Inflamm Bowel Dis 2014; 20: 892-900